<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31481063</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Viral respiratory tract infections in young children with cystic fibrosis: a prospective full-year seasonal study.</ArticleTitle><Pagination><StartPage>111</StartPage><MedlinePgn>111</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">111</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-019-1208-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Viral respiratory tract infections are common during early childhood. How they impact cystic fibrosis lung disease history in young children is poorly known. The principal aim of our study was to determinate respiratory tract infections frequency in this cystic fibrosis young population. Secondary outcomes were nature of viral agents recovered and impact of such infections.</AbstractText><AbstractText Label="METHODS">We conducted a prospective cohort study of 25 children affected by cystic fibrosis and aged less than 2&#x2009;years. Nasal samplings were taken systematically monthly or bimonthly with additional samples taken during respiratory tract infections episodes. Ten pathogens were tested by a combination of five duplex RT-PCRs or PCRs: influenza A and B, respiratory syncytial virus (RSV), metapneumovirus (MPV), rhinovirus/enterovirus (RV/EV)), coronavirus (HKU1, NL63, 229E and OC43), parainfluenza virus (1-4), adenovirus and bocavirus (Respiratory Multi-Well System MWS r-gene&#xae;, BioM&#xe9;rieux, Marcy l'&#xc9;toile, France). Cycle thresholds (CTs) were reported for all positive samples and considered positive for values below 40. Quantitative variables were compared using a nonparametric statistical test (Wilcoxon signed rank for paired comparisons). Pearson's correlation coefficient (r) was used to assess relationships between two variables. Statistical analyses were performed using SAS v9.4 (SAS Institute, Cary, NC, USA) or GraphPad Prism V6.00 (GraphPad Software, La Jolla, CA, USA). The significance level was set at 0.05.</AbstractText><AbstractText Label="RESULTS">The mean age at inclusion was 9.6&#x2009;&#xb1;&#x2009;6.7&#x2009;months. The patients had 3.4&#x2009;&#xb1;&#x2009;1.7 respiratory tract infections episodes per child per year. Forty-four respiratory tract infections (69%) were associated with virus: rhinovirus and enterovirus (RV/EV) were implied in 61% of them and respiratory syncytial virus (RSV) in 14%. Only one patient required hospitalization for lower respiratory tract infections. 86% of the patients were treated by antibiotics for a mean of 13.8&#x2009;&#xb1;&#x2009;6.2&#x2009;days. RSV infections (n&#x2009;=&#x2009;6) were usually of mild severity.</AbstractText><AbstractText Label="CONCLUSIONS">Respiratory tract infections in young children with cystic fibrosis were of mild severity, rarely requiring hospitalization. Unsurprisingly, RV/EV were the most frequent agents. RSV-related morbidity seems low in this population. This raises the question of the usefulness of RSV preventive medication in this young population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eymery</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-1647-8562</Identifier><AffiliationInfo><Affiliation>Service de pneumologie p&#xe9;diatrique et CRCM enfant, H&#xf4;pital Femme M&#xe8;re Enfant, Hospices civils de Lyon, Bron, France. mathilde.eymery@chu-lyon.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de ressources et de comp&#xe9;tence pour la Mucoviscidose, 59 boulevard Pinel, 69677, BRON CEDEX, France. mathilde.eymery@chu-lyon.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morfin</LastName><ForeName>Florence</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory of Virology, Institut des Agents Infectieux, Groupement Hospitalier Nord, F69317, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre National de R&#xe9;f&#xe9;rence des virus respiratoires France Sud, Hospices Civils de Lyon, Lyon, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facult&#xe9; de Pharmacie, CIRI, Inserm U1111 CNRS UMR5308, Virpath, Univ Lyon, Universit&#xe9; Lyon 1, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doleans-Jordheim</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Equipe de Recherche, Bact&#xe9;ries Pathog&#xe8;nes Opportunistes et Environnement, UMR CNRS 5557 Ecologie Microbienne, Universit&#xe9; Lyon 1 &amp; VetAgro Sup, Villeurbanne, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Bacteriology, Institut des Agents Infectieux, Groupement Hospitalier Nord, Hospices Civils de Lyon, F69317, Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perceval</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de pneumologie p&#xe9;diatrique et CRCM enfant, H&#xf4;pital Femme M&#xe8;re Enfant, Hospices civils de Lyon, Bron, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohlmann</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de pneumologie p&#xe9;diatrique et CRCM enfant, H&#xf4;pital Femme M&#xe8;re Enfant, Hospices civils de Lyon, Bron, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mainguy</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de pneumologie p&#xe9;diatrique et CRCM enfant, H&#xf4;pital Femme M&#xe8;re Enfant, Hospices civils de Lyon, Bron, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reix</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de pneumologie p&#xe9;diatrique et CRCM enfant, H&#xf4;pital Femme M&#xe8;re Enfant, Hospices civils de Lyon, Bron, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UMR 5558 (EMET). CNRS, LBBE, Universit&#xe9; de Lyon, Villeurbanne, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003550" MajorTopicYN="N">Cystic Fibrosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="N">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="N">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="N">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="Y">Seasons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="N">Viruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Cystic fibrosis</Keyword><Keyword MajorTopicYN="N">Respiratory virus</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31481063</ArticleId><ArticleId IdType="pmc">PMC6724274</ArticleId><ArticleId IdType="doi">10.1186/s12985-019-1208-7</ArticleId><ArticleId IdType="pii">10.1186/s12985-019-1208-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Asner S, Waters V, Solomon M, et al. Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros. 2012;11(5):433&#x2013;439. doi: 10.1016/j.jcf.2012.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcf.2012.04.006</ArticleId><ArticleId IdType="pmc">PMC7105203</ArticleId><ArticleId IdType="pubmed">22579414</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns JL, Emerson J, Kuypers J, et al. Respiratory viruses in children with cystic fibrosis: viral detection and clinical findings. Influenza Other Respir Viruses. 2012;6(3):218&#x2013;223. doi: 10.1111/j.1750-2659.2011.00292.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-2659.2011.00292.x</ArticleId><ArticleId IdType="pmc">PMC4941093</ArticleId><ArticleId IdType="pubmed">21955319</ArticleId></ArticleIdList></Reference><Reference><Citation>Cousin M, Molinari N, Foulongne V, et al. Rhinovirus-associated pulmonary exacerbations show a lack of FEV1 improvement in children with cystic fibrosis. Influenza Other Respir Viruses. 2016;10(2):109&#x2013;112. doi: 10.1111/irv.12353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12353</ArticleId><ArticleId IdType="pmc">PMC4746558</ArticleId><ArticleId IdType="pubmed">26493783</ArticleId></ArticleIdList></Reference><Reference><Citation>Dijkema JS, van Ewijk BE, Wilbrink B, et al. Frequency and duration of rhinovirus infections in children with cystic fibrosis and healthy controls: a longitudinal cohort study. Pediatr Infect Dis J. 2016;35(4):379&#x2013;383. doi: 10.1097/INF.0000000000001014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001014</ArticleId><ArticleId IdType="pubmed">26658528</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieninger E, Singer F, Tapparel C, et al. High rhinovirus burden in lower airways of children with cystic fibrosis. Chest. 2013;143(3):782&#x2013;790. doi: 10.1378/chest.12-0954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.12-0954</ArticleId><ArticleId IdType="pubmed">23188200</ArticleId></ArticleIdList></Reference><Reference><Citation>Korten I, Kieninger E, Klenja S, et al. Respiratory viruses in healthy infants and infants with cystic fibrosis: a prospective cohort study. Thorax 2017.</Citation><ArticleIdList><ArticleId IdType="pubmed">28778921</ArticleId></ArticleIdList></Reference><Reference><Citation>Miro-Canis S, Capilla-Rubio S, Marzo-Checa L, et al. Multiplex PCR reveals that viruses are more frequent than bacteria in children with cystic fibrosis. J Clin Virol. 2017;86:1&#x2013;4. doi: 10.1016/j.jcv.2016.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2016.11.004</ArticleId><ArticleId IdType="pmc">PMC7106555</ArticleId><ArticleId IdType="pubmed">27886635</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller L, Mack I, Tapparel C, et al. Human rhinovirus types and association with respiratory symptoms during the first year of life. Pediatr Infect Dis J. 2015;34(8):907&#x2013;909. doi: 10.1097/INF.0000000000000758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000000758</ArticleId><ArticleId IdType="pubmed">26020408</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ewijk BE, van der Zalm MM, Wolfs TF, et al. Prevalence and impact of respiratory viral infections in young children with cystic fibrosis: prospective cohort study. Pediatrics. 2008;122(6):1171&#x2013;1176. doi: 10.1542/peds.2007-3139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3139</ArticleId><ArticleId IdType="pubmed">19047230</ArticleId></ArticleIdList></Reference><Reference><Citation>Etherington C, Naseer R, Conway SP, et al. The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation. J Cyst Fibros. 2014;13(1):49&#x2013;55. doi: 10.1016/j.jcf.2013.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcf.2013.06.004</ArticleId><ArticleId IdType="pubmed">23891398</ArticleId></ArticleIdList></Reference><Reference><Citation>Flight WG, Bright-Thomas RJ, Tilston P, et al. Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis. Thorax. 2014;69(3):247&#x2013;253. doi: 10.1136/thoraxjnl-2013-204000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2013-204000</ArticleId><ArticleId IdType="pubmed">24127019</ArticleId></ArticleIdList></Reference><Reference><Citation>Frickmann H, Jungblut S, Hirche TO, et al. Spectrum of viral infections in patients with cystic fibrosis. Eur J Microbiol Immunol (Bp) 2012;2(3):161&#x2013;175. doi: 10.1556/EuJMI.2.2012.3.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/EuJMI.2.2012.3.1</ArticleId><ArticleId IdType="pmc">PMC3962751</ArticleId><ArticleId IdType="pubmed">24688762</ArticleId></ArticleIdList></Reference><Reference><Citation>Goffard A, Lambert V, Salleron J, et al. Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients. J Clin Virol. 2014;60(2):147&#x2013;153. doi: 10.1016/j.jcv.2014.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2014.02.005</ArticleId><ArticleId IdType="pmc">PMC7108260</ArticleId><ArticleId IdType="pubmed">24637203</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoek RA, Paats MS, Pas SD, et al. Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients. Scand J Infect Dis. 2013;45(1):65&#x2013;69. doi: 10.3109/00365548.2012.708942.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2012.708942</ArticleId><ArticleId IdType="pubmed">22992129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wark PA, Tooze M, Cheese L, Whitehead B, et al. Viral infections trigger exacerbations of cystic fibrosis in adults and children. Eur Respir J. 2012;40(2):510&#x2013;512. doi: 10.1183/09031936.00202311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00202311</ArticleId><ArticleId IdType="pubmed">22855475</ArticleId></ArticleIdList></Reference><Reference><Citation>Abman SH, Ogle JW, Butler-Simon N, et al. Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis. J Pediatr. 1988;113(5):826&#x2013;830. doi: 10.1016/S0022-3476(88)80008-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(88)80008-8</ArticleId><ArticleId IdType="pubmed">3183835</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong D, Grimwood K, Carlin JB, et al. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol. 1998;26(6):371&#x2013;379. doi: 10.1002/(SICI)1099-0496(199812)26:6&lt;371::AID-PPUL1&gt;3.0.CO;2-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1099-0496(199812)26:6&lt;371::AID-PPUL1&gt;3.0.CO;2-N</ArticleId><ArticleId IdType="pubmed">9888211</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinson J, Nicholson KG, Cancio E, et al. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax. 1996;51(11):1115&#x2013;1122. doi: 10.1136/thx.51.11.1115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.51.11.1115</ArticleId><ArticleId IdType="pmc">PMC1090523</ArticleId><ArticleId IdType="pubmed">8958895</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsey BW, Gore EJ, Smith AL, et al. The effect of respiratory viral infections on patients with cystic fibrosis. Am J Dis Child. 1989;143(6):662&#x2013;668.</Citation><ArticleIdList><ArticleId IdType="pubmed">2543212</ArticleId></ArticleIdList></Reference><Reference><Citation>Somayaji R, Goss CH, Khan U, et al. Cystic fibrosis pulmonary exacerbations attributable to respiratory syncytial virus and influenza: a population-based study. Clin Infect Dis. 2017;64(12):1760&#x2013;1767. doi: 10.1093/cid/cix203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix203</ArticleId><ArticleId IdType="pmc">PMC5848232</ArticleId><ArticleId IdType="pubmed">28329304</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz J, Eber E, Resch B. Respiratory syncytial virus infection-associated hospitalization rates in infants and children with cystic fibrosis. Pediatr Infect Dis J. 2017;36(6):545&#x2013;548. doi: 10.1097/INF.0000000000001501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000001501</ArticleId><ArticleId IdType="pubmed">28005688</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchs C, Dalphin ML, Sanchez S, et al. Palivizumab prophylaxis in infants with cystic fibrosis does not delay first isolation of Pseudomonas aeruginosa or Staphylococcus aureus. Eur J Pediatr. 2017;176(7):891&#x2013;897. doi: 10.1007/s00431-017-2926-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-017-2926-8</ArticleId><ArticleId IdType="pubmed">28508992</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangell CL, Shackleton C, Poreddy S, et al. Feasibility of parental collected nasal swabs for virus detection in young children with cystic fibrosis. J Cyst Fibros. 2014;13(6):661&#x2013;666. doi: 10.1016/j.jcf.2014.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcf.2014.02.009</ArticleId><ArticleId IdType="pmc">PMC7105194</ArticleId><ArticleId IdType="pubmed">24637444</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerson J, Cochrane E, McNamara S, et al. Home self-collection of nasal swabs for diagnosis of acute respiratory virus infections in children with cystic fibrosis. J Pediatric Infect Dis Soc. 2013;2(4):345&#x2013;351. doi: 10.1093/jpids/pit039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jpids/pit039</ArticleId><ArticleId IdType="pmc">PMC3869469</ArticleId><ArticleId IdType="pubmed">24363931</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieninger E, Vareille M, Kopf BS, et al. Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis. Eur Respir J. 2012;39(2):297&#x2013;304. doi: 10.1183/09031936.00054511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00054511</ArticleId><ArticleId IdType="pubmed">21719483</ArticleId></ArticleIdList></Reference><Reference><Citation>Esther CR, Jr, Lin FC, Kerr A, et al. Respiratory viruses are associated with common respiratory pathogens in cystic fibrosis. Pediatr Pulmonol. 2014;49(9):926&#x2013;931. doi: 10.1002/ppul.22917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.22917</ArticleId><ArticleId IdType="pubmed">24167159</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiatt PW, Grace SC, Kozinetz CA, et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics. 1999;103(3):619&#x2013;626. doi: 10.1542/peds.103.3.619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.103.3.619</ArticleId><ArticleId IdType="pubmed">10049966</ArticleId></ArticleIdList></Reference><Reference><Citation>American Academy of Pediatrics Committee on Infectious D, American Academy of Pediatrics Bronchiolitis Guidelines C Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134(2):e620&#x2013;e638. doi: 10.1542/peds.2014-1666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2014-1666</ArticleId><ArticleId IdType="pubmed">25070304</ArticleId></ArticleIdList></Reference><Reference><Citation>Flight WG, Bright-Thomas RJ, Tilston P, et al. Chronic rhinovirus infection in an adult with cystic fibrosis. J Clin Microbiol. 2013;51(11):3893&#x2013;3896. doi: 10.1128/JCM.01604-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01604-13</ArticleId><ArticleId IdType="pmc">PMC3889793</ArticleId><ArticleId IdType="pubmed">23966488</ArticleId></ArticleIdList></Reference><Reference><Citation>Psoter KJ, De Roos AJ, Wakefield J, et al. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis. Clin Microbiol Infect. 2013;19(11):E483&#x2013;E489. doi: 10.1111/1469-0691.12272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1469-0691.12272</ArticleId><ArticleId IdType="pubmed">23795938</ArticleId></ArticleIdList></Reference><Reference><Citation>Psoter KJ, De Roos AJ, Wakefield J, et al. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis. BMC Infect Dis. 2017;17(1):411. doi: 10.1186/s12879-017-2511-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2511-9</ArticleId><ArticleId IdType="pmc">PMC5466772</ArticleId><ArticleId IdType="pubmed">28599639</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>